Moti Ramgopal, Midway Research

Midway Research
Dr. Ramgopal is the Founder of Midway Immunology and Research Center and an Associate Professor of Medicine at Florida State University. Dr. Ramgopal is Board Certified and is a Fellow of the American College of Physicians and the Infectious Diseases Society of America.

Presenter Of 1 Presentation

Oral abstract session

OAB0403 - Pooled analysis of 4 international trials of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older demonstrating safety and efficacy: Week 48 results

Room
Abstract Sessions On-Demand Channel

Presenter Of 1 Presentation

Oral abstract session

Pooled analysis of 4 international trials of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older demonstrating safety and efficacy: Week 48 results

Room
Abstract Sessions On-Demand Channel

Presenter Of 1 Presentation

Oral abstract session

Pooled analysis of 4 international trials of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older demonstrating safety and efficacy: Week 48 results

Room
Abstract Sessions On-Demand Channel